Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 09. July 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9480  Previews Next
   
   Articles 1 - 20 / 189581  
   
Overview of clear cell renal cell carcinoma: from mechanisms to clinical.
Front Med (Lausanne)
Yang H, Zhang X, Ji Q, Sheng X.
PMID: 42422841 [PubMed]


Late Renal Cell Carcinoma Metastasis Mimicking an Arteriovenous Malformation in the Parotid and Masseter Region: A Diagnostic Pitfall.
Cureus
Huerta Diaz LA, Lopez Alanis BA, Ortiz Villeda FE, Treviño Lozano MA, Muñoz-Maldonado GE.
PMID: 42422606 [PubMed]


Magnetic Resonance Imaging-based Prostate Cancer Diagnosis Using Principal Component Analysis and Machine Learning Algorithms.
J Med Phys
Samta N, Sureka CS, Sarasanandarajah S, Jeevanram RK.
PMID: 42422134 [PubMed]


Navigating Recurrence in Clear Cell Renal Cell Carcinoma after Adjuvant Immunotherapy.
J Kidney Cancer VHL
Sunny G, Ravichandran S, Patnaik A, Yadav R.
PMID: 42422057 [PubMed]


Evolution of the prostate cancer diagnostic paradigm: integrated evidence and clinical pathways from targeted biopsy to biopsy-free strategy.
Front Oncol
Liu Z, Wu J, Lu Q, Li Y, Yang Y.
PMID: 42421680 [PubMed]


Keratin 17 immunocytochemistry in urine cytology for urothelial carcinoma detection: Diagnostic performance and interobserver agreement in a prospective real-world cohort.
Cancer Cytopathol
Barth G, Koch S, Ecke TH.
PMID: 42421607 [PubMed - indexed for MEDLINE]


Diabetes Is an Independent Risk Factor for Radiation-Induced Hematuria After Robotic Stereotactic Body Radiotherapy for Prostate Cancer.
Int J Urol
Elting L, Almohtasib J, Francisco IFS, Pérez-Londoño A, Al-Faouri R, Kaplan I, Aronovitz J, Mehta P, Gershman B, Olumi AF, Aghdam N.
PMID: 42421489 [PubMed - indexed for MEDLINE]


Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of '-mabs'?
J Pathol
Schepisi G, Torresan I, Giunta EF, Bleve S, Brighi N, Tassinari E, Zanuccoli S, Cursano MC, Lolli C.
PMID: 42420213 [PubMed - as supplied by publisher]


Molecular Profiling of Urothelial Bladder Cancer: Bridging Tumor Biology and Clinical Decision-making.
Eur Urol Oncol
Thibault C, Blons H, Allory Y, Harba A, Roumiguié M, Seisen T, Marcq G, Bajeot AS, Leon P, Masson-Lecomte A, Pradère B, Xylinas E, Prost D, Gabriel PE, Laurent-Puig P, Rouprêt M, Audenet F, Cancer Committee of The French Association of Urology (CC-AFU).
PMID: 42420157 [PubMed - as supplied by publisher]


MRI-based Response Assessment of Neoadjuvant Systemic Immunotherapy in Muscle-invasive Bladder Cancer: An Analysis of Inter-radiologist Variability and Diagnostic Accuracy in three Prospective Clinical Trials.
Eur Urol Oncol
Greidanus J, van Dijk-de Haan MC, Messina A, Calareso G, Bruining A, Westerink B, Dehghanpour A, Tissier R, van Dorp J, Stockem CF, Pipinikas C, Mertens LS, van der Poel HG, Beets-Tan RGH, van Rhijn BWG, Giannatempo P, van der Heijden MS, Trebeschi S, Boellaard TN.
PMID: 42420156 [PubMed - as supplied by publisher]


Development and acceptability of gist-based decision aids for prostate and breast cancer screening: a two-phase qualitative interview study in an online setting.
BMJ Open
Nalavenkata S, Bergengren O, Lynch K, Emard N, Austria M, Martin S, Ogbennaya G, Dualeh K, Stevanovic K, Patel MI, Gonsky J, Vickers A, Fagerlin A, Hamilton JG, Hay JL, Carlsson S.
PMID: 42419884 [PubMed - indexed for MEDLINE]


(Cost-)effectiveness of focal therapy versus radical therapy (standard of care) in the treatment of men with intermediate-risk prostate cancer: study protocol for the ENFORCE focal randomised controlled trial.
BMJ Open
Te Molder LPW, Sedelaar JPM, Bomers JGR, Boomsma MF, de Haan TD, van Melick HHE, Meijerink MR, Beerlage HP, van Aubel O, Collette ER, Grutters JPC, Hannink G, Rovers MM, Fütterer JJ, ENFORCE Focal consortium.
PMID: 42419881 [PubMed - indexed for MEDLINE]


Advances in systemic therapies for advanced prostate cancer.
BMJ
Childs DS, Hahn AW, Ravi P, Orme JJ.
PMID: 42419784 [PubMed - indexed for MEDLINE]


Genetics and Screening in Prostate Cancer.
Surg Clin North Am
Partuzo JGR, Mora-Garijo B, Hwang J.
PMID: 42419315 [PubMed - indexed for MEDLINE]


Identification and verification of immunogenic cell death-related signatures derived from bone metastasis of prostate cancer based on multi-omics and machine learning algorithms.
Comput Biol Chem
Ma W, Mei W, Guang L, Yang Q, Xu M, Zhou H.
PMID: 42419189 [PubMed - as supplied by publisher]


The cancer/testis antigens represent promising targets for the development of new therapies against melanoma.
Pathol Res Pract
Lanius SL, Pacheco BS, Sousa FSS, Ehlert ME, Ferreira VG, Collares TV, Seixas FK.
PMID: 42419156 [PubMed - as supplied by publisher]


Integrating Natural Language Processing With ChatGPT to Improve Quality of Artificial Intelligence Summaries of Prostate Cancer Consultations.
JCO Clin Cancer Inform
Friedrich NA, Das SK, Luu M, Daniels JP, Heard J, Barsegyan A, Freedland SJ, Spiegel B, Kokorowski PK, Gonzalez Hernandez G, Daskivich TJ.
PMID: 42418754 [PubMed - indexed for MEDLINE]


Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology.
JCO Precis Oncol
Kamran SC, Borges M, Michalski J, Lee WR, Sandler HM, Crook J, Pollack A, Hurwitz MD, Valicenti RK, Bruner DW, Lukka H, Jones CU, Roach M 3rd, Lawton C, Rosenthal SA, Pisansky TM, Spratt D, Vapiwala N, Efstathiou J, Miyamoto D, Mouw K, Vyfhuis M, Le QT, Willers H, Van Allen E, Huang F, Bahary JP, Helou J, Pugh SL, Wenzel J, Tran P.
PMID: 42418740 [PubMed - indexed for MEDLINE]


Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.
JCO Precis Oncol
Sweeney CJ, Krishna V, Krishna V, Neema A, Tarsode A, Subhash VV, Horvath LG, Kench JG, Stockler MR, Yip S, Thomas H, Swami U, Zhang H, Sonawane S, Abuzeid WM, Nimgaonkar V, Tiu E, Watson D, Kiedrowski L, Royce TJ, Yang DD, Tran PT, Ryan CJ, Nguyen PL, Morgans AK, Joshi A, Agarwal N, Davis ID.
PMID: 42418739 [PubMed - indexed for MEDLINE]


Shallow Whole-Genome Sequencing to Assess Genomic Instability and Predict Treatment Response in Metastatic Castration-Resistant Prostate Cancer.
JCO Precis Oncol
Slootbeek PHJ, Quint YM, Kokke JJR, Pamidimarri Naga S, Luna-Velez MV, Ligtenberg MJL, de Voer RM, Mehra N.
PMID: 42418738 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 189581    Page 1 of 9480  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1